A high-yield production of a peptide vaccine in transgenic plants is descri
bed here. A 21-mer peptide, which confers protection to dogs against challe
nge with virulent canine parvovirus, has been expressed in transgenic plant
s as an aminoterminal translational fusion with the GUS gene. Transformants
mere selected on the basis of their GUS activities, showing expression lev
els of the recombinant protein up to 3% of the total leaf soluble protein,
a production yield comparable to that obtained with the same epitope expres
sed by chimeric plant viruses. The immunogenicity of the plant-derived pept
ide mas demonstrated in mice immunized either intraperitoneally or orally w
ith transgenic plant extracts, providing the suitability of the GUS fusions
approach for low-cost production of peptide vaccines. (C) 2001 Federation
of European Biochemical Societies. Published by Elsevier Science B.V. All r
ights reserved.